Smoking cessation: an economic analysis and review of varenicline
Michele A FaulknerCreighton University School of Pharmacy and Health Professions, Omaha, NE, USAAbstract: Despite efforts to decrease tobacco use, smoking continues to be a leading cause of preventable morbidity and premature death. The associated economic burden is substantial, both in the form of...
Main Author: | Michele A Faulkner |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-06-01
|
Series: | ClinicoEconomics and Outcomes Research |
Online Access: | http://www.dovepress.com/smoking-cessation-an-economic-analysis-and-review-of-varenicline-a3288 |
Similar Items
-
Smoking cessation therapy with varenicline
by: Uma M Mohanasundaram, et al.
Published: (2008-06-01) -
Smoking cessation in Asians: focus on varenicline
by: Xiao D, et al.
Published: (2015-04-01) -
Varenicline and evaluated outcomes in smoking cessation programmes
by: P. Santus, et al.
Published: (2015-11-01) -
Smoking cessation in Asians: focus on varenicline [Corrigendum]
by: Xiao D, et al.
Published: (2015-07-01) -
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
by: Jon O Ebbert, et al.
Published: (2010-09-01)